Stock DEPOMED INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Depomed Inc Nasdaq

Equities

US2499081048

Chart calendar Depomed Inc

b87099dac3364ff7cd.0esqahdibgfy6BOP4EIQqew8zZUukfhlTFUUf-Ac0BA.55ETKEY2WFWQkXH41DN08Y1ov-9qo4sLDTJRD7FOl3iprWs4fyoDZr-ZQg~b1fd9e64e41d772617fa97c499298a6d

Upcoming events on Depomed Inc

05/05/2024 Q1 2024 Earnings Release After hours
06/05/2024 21:30 Q1 2024 Earnings Call
13/05/2024 17:00 Citizens JMP Life Sciences Conference
23/05/2024 18:30 Annual General Meeting
31/07/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)
11/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Depomed Inc

09/04/2024 21:00 LD Micro Invitational Conference
11/03/2024 20:30 Q4 2023 Earnings Call
11/03/2024 20:01 Q4 2023 Earnings Release
08/11/2023 21:30 Q3 2023 Earnings Call
08/11/2023 21:01 Q3 2023 Earnings Release
03/08/2023 21:30 Q2 2023 Earnings Call
03/08/2023 21:04 Q2 2023 Earnings Release
26/07/2023 Extraordinary Shareholders Meeting - M&A Vote
10/05/2023 18:30 Annual General Meeting
09/05/2023 16:30 Q1 2023 Earnings Call
09/05/2023 12:15 Q1 2023 Earnings Release
27/04/2023 00:00 Planet MicroCap Showcase
25/04/2023 13:30 Acquisition of Spectrum Pharmaceuticals Inc by Assertio Holdings, Inc Call
22/03/2023 19:15 Sidoti Spring Small-Cap Conference
11/03/2023 Roth Conference
08/03/2023 21:30 Q4 2022 Earnings Call
08/03/2023 21:01 Q4 2022 Earnings Release
22/02/2023 14:30 Winter Wonderland Best Ideas Investor Conference
14/02/2023 SVB Securities Global Biopharma Conference
08/01/2023 JP Morgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		230
227
1.06%		106
106
0.28%		111
108
2.36%		156
153
1.9%		152
153
-0.55%
117

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		22,4
5,00
348.26%		48,8
47,7
2.3%		102
99,4
2.23%		67,7
72,6
-6.64%
24,2

EBIT
Million USD		Released
Forecast
Spread 		137
129
6.21%		20,8
12,7
63.84%		19,8
39,4
-49.84%		39,4
54,4
-27.58%		-244
-213
-14.57%
-12,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-0,55
0,92
-160.37%		31,2
38,4
-18.82%		-254
-224
-13.27%
-13,7

Net income
Million USD		Released
Forecast
Spread 		-217
-42,7
-409.22%		-28,1
-9,01
-212.23%		-1,28
0,30
-532.77%		110
69,3
58.26%		-332
-276
-20.09%
-11,8

EPS
USD		Released
Forecast
Spread 		-12,3
-2,40
-411.67%		-1,08
-0,36
-200%		-0,03
0,01
-400%		2,03
0,91
121.92%		-4,67
-3,41
-36.95%
-0,12

Announcement Date09/03/2011/03/2109/03/2208/03/2311/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		33,3
30,8
8.3%		36,5
33,1
10.5%		35,1
31,8
10.55%		34,2
31,3
9.13%		50,4
47,4
6.14%		42,5
37,6
12.83%		41,0
39,8
2.9%		35,6
50,4
-29.35%		33,0
33,8
-2.45%
29,5


29,8


28,6


29,4




EBITDA
Million USD		Released
Forecast
Spread 		17,8
17,1
4.4%		23,9
17,4
37.4%		22,9
16,4
39.28%		21,4
15,7
36.98%		33,4
30,4
9.63%		25,6
22,0
16.6%		24,8
23,0
7.68%		12,9
18,9
-31.77%		4,45
6,88
-35.35%
5,72


7,07


5,62


5,18




EBIT
Million USD		Released
Forecast
Spread 		10,4
15,9
-34.32%		11,6
16,3
-28.95%		10,8
10,1
7.06%		6,43
8,36
-23%		10,6
15,9
-33.34%		4,64
13,5
-65.67%		12,4
14,9
-16.72%		13,6
7,26
87.17%		-32,3
-1,37
-2267.56%
-3,20


-2,49


-3,70


-3,38


4,08

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5,04
6,51
-22.55%		9,78
6,02
62.46%		8,43
5,65
49.23%		4,38
4,55
-3.61%		8,58
15,2
-43.71%		-5,59
10,2
-154.7%		12,3
12,3
0.3%		-229
10,2
-2345.73%		-31,9
-2,12
-1407.8%
-3,45


-2,74


-3,95


-3,63


3,38

Net income
Million USD		Released
Forecast
Spread 		4,61
6,18
-25.47%		9,06
4,75
90.66%		7,83
3,75
108.67%		4,17
3,52
18.55%		88,6
48,2
83.78%		-3,48
8,49
-141.01%		8,47
10,2
-17.02%		-280
6,39
-4476.77%		-57,4
-1,87
-2961.3%
-2,93


-2,41


-3,32


-3,10


3,21

EPS
USD		Released
Forecast
Spread 		0,10
0,12
-16.67%		0,20
0,09
122.22%		0,16
0,08
106.91%		0,08
0,07
22.61%		1,34
0,58
132.91%		-0,07
0,13
-153.54%		0,13
0,14
-9.88%		-3,42
0,07
-4706.06%		-0,61
-0,02
-2950%
-0,03


-0,03


-0,04


-0,03


0,03

Announcement Date09/03/2209/05/2208/08/2208/11/2208/03/2309/05/2303/08/2308/11/2311/03/24-----

Upcoming sector events for Depomed Inc

Today 06:30 NOVO NORDISK A/S: Q1 2024 Earnings Release
Today 12:30 ORGANON & CO.: Q1 2024 Earnings Release
02/05/2024 SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected)
02/05/2024 AARTI DRUGS LIMITED: Q4 2024 Earnings Release
02/05/2024 ALK-ABELLÓ A/S: Q1 2024 Earnings Release
02/05/2024 DEVA HOLDING: Q1 2024 Earnings Release (Projected)
03/05/2024 11:00 AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
05/05/2024 GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI: Q1 2024 Earnings Release (Projected)
05/05/2024 PLIANT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
05/05/2024 AVADEL PHARMACEUTICALS PLC: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Depomed Inc

Today BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release
Today AMGEN INC.: Q1 2024 Earnings Release
01/05/2024 21:05 CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release
01/05/2024 21:05 JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release
01/05/2024 11:45 PFIZER, INC.: Q1 2024 Earnings Release
01/05/2024 08:00 HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement
01/05/2024 07:00 GSK PLC: Q1 2024 Earnings Release
30/04/2024 INNOVIVA, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. ASRT Stock
  4. Stock
  5. Calendar Depomed Inc